- The extracorporeal circulation with transdiaphragmatic approach in living-donor liver transplantation for hepatoblastoma with atrial extension of tumor thrombus
-
Kasahara M, Sakamoto S, Yanagi Y, Uchida H, Shimizu S, Mimori K, Kameoka Y, Fukuda A
- KMID: 2509317
- Korean J Transplant.
- 2020 Dec;34(Supple 1):S127.
- doi: 10.4285/ATW2020.OR-1076
Background: Surgical intervention for hepatoblastoma (HB) with tumor thrombi extending into the inferior vena cava (IVC) and the right atrium (RA) might require careful planning of the surgical procedures, including... -
- CITED
-
- Close
- SHARE
-
- Close
- Reconsideration of pathology and management for acute antibodymediated rejection in pediatric ABO incompatible transplantation
-
Yanagi Y, Sakamoto S, Mimori K, Nakao M, Shimizu S, Uchida H, Fukuda A, Kasahara M
- KMID: 2521178
- Korean J Transplant.
- 2021 Oct;35(Supple 1):S8.
- doi: 10.4285/ATW2021.OP-1099
Background: The management and outcome of ABO incompatible liver transplantation (ABO-I LT) has been improved in the decades. Recently, latest pathological evaluation of acute antibody-mediated rejection (AMR) was introduced through... -
- CITED
-
- Close
- SHARE
-
- Close
- The impact of donor-specific alloantibodies on chronic antibodymediated rejection after pediatric living donor liver transplantation
-
Shimizu S, Sakamoto S, Fukuda A, Yanagi Y, Uchida H, Mimori K, Nakao T, Yamada M, Yoshioka T, Kasahara M
- KMID: 2521267
- Korean J Transplant.
- 2021 Oct;35(Supple 1):S42.
- doi: 10.4285/ATW2021.OR-1094
Background: The development of anti-human leukocyte antigen donor-specific alloantibodies (DSA) after living donor liver transplantation (LDLT) can lead to chronic antibody-mediated rejection (cAMR). This study aimed to analyze the detail... -
- CITED
-
- Close
- SHARE
-
- Close
- Vascular reconstruction and long-term outcome of living domino liver transplantation in children
-
Shimizu S, Sakamoto S, Kameoka Y, Mimori K, Uchida H, Yanagi Y, Fukuda A, Horikawa R, Kasahara M
- KMID: 2509141
- Korean J Transplant.
- 2020 Dec;34(Supple 1):S21.
- doi: 10.4285/ATW2020.OP-1176
Background: A native liver of maple syrup urine disease (MSUD) patients can be used as a graft to non-MSUD patients with endstage liver disease because an extrahepatic enzyme activity can... -
- CITED
-
- Close
- SHARE
-
- Close
